Amicus Therapeutics, Inc. Profile Avatar - Palmy Investing

Amicus Therapeutics, Inc.

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults wit…

Biotechnology
US, Philadelphia [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of FOLD's Analysis
CIK: 1178879 CUSIP: 03152W109 ISIN: US03152W1099 LEI: - UEI: -
Secondary Listings
FOLD has no secondary listings inside our databases.